Another mediator of PGC-1α in diabetic kidney disease is the PKM2, an enzyme catalyzing the last step of glycolysis, which is downregulated in such patients while podocyte-specific PKM2-knockout animal models showed worse histopathological features [37]. This evidence concerns the gene PKM and diabetic kidney disease.